Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2, Multi-center, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia

NCT04500132 is registered in ClinicalTrials.gov with Enzychem Lifesciences Corporation as lead sponsor.

NCT NCT04500132
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04500132 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2, Multi-center, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Safety and Efficacy of EC-18 in COVID-19 Infection to Pneumonia
Lead sponsor
Enzychem Lifesciences Corporation
Phase
Phase 2
Overall status
Completed
Start date
May 28, 2020
Completion date
February 15, 2021
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19